Literature DB >> 15376341

Liver transplantation from non-heart-beating donors: current status and future prospects.

Srikanth Reddy1, Miguel Zilvetti, Jens Brockmann, Andrew McLaren, Peter Friend.   

Abstract

Liver transplantation is the treatment of choice for many patients with acute and chronic liver failure, but its application is limited by a shortage of donor organs. Donor organ shortage is the principal cause of increasing waiting lists, and a number of patients die while awaiting transplantation. Non-heart-beating donor (NHBD) livers are a potential means of expanding the donor pool. This is not a new concept. Prior to the recognition of brainstem death, organs were retrieved from deceased donors only after cardiac arrest. Given the preservation techniques available at that time, this restricted the use of extrarenal organs for transplantation. In conclusion, after establishment of brain death criteria, deceased donor organs were almost exclusively from heart-beating donors (HBDs). To increase organ availability, there is now a resurgence of interest in NHBD liver transplantation. This review explores the basis for this and considers some of the published results.

Entities:  

Mesh:

Year:  2004        PMID: 15376341     DOI: 10.1002/lt.20268

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  22 in total

Review 1.  Strategies to optimize the use of marginal donors in liver transplantation.

Authors:  Daniele Pezzati; Davide Ghinolfi; Paolo De Simone; Emanuele Balzano; Franco Filipponi
Journal:  World J Hepatol       Date:  2015-11-18

2.  Inhibition of inducible nitric oxide synthase prevents graft injury after transplantation of livers from rats after cardiac death.

Authors:  Yanjun Shi; Hasibur Rehman; Gary L Wright; Zhi Zhong
Journal:  Liver Transpl       Date:  2010-11       Impact factor: 5.799

Review 3.  Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature.

Authors:  Dronacharya Routh; Sudeep Naidu; Sanjay Sharma; Priya Ranjan; Rajesh Godara
Journal:  J Clin Exp Hepatol       Date:  2013-12-05

4.  Diluted blood reperfusion as a model for transplantation of ischemic rat livers: alanine aminotransferase is a direct indicator of viability.

Authors:  K Uygun; H Tolboom; M L Izamis; B Uygun; N Sharma; H Yagi; A Soto-Gutierrez; M Hertl; F Berthiaume; M L Yarmush
Journal:  Transplant Proc       Date:  2010-09       Impact factor: 1.066

5.  Porcine Isolated Liver Perfusion for the Study of Ischemia Reperfusion Injury: A Systematic Review.

Authors:  Francesca Maione; Nicholas Gilbo; Silvia Lazzaro; Peter Friend; Giovanni Camussi; Renato Romagnoli; Jacques Pirenne; Ina Jochmans; Diethard Monbaliu
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

6.  Sanguineous normothermic machine perfusion improves hemodynamics and biliary epithelial regeneration in donation after cardiac death porcine livers.

Authors:  Qiang Liu; Ahmed Nassar; Kevin Farias; Laura Buccini; William Baldwin; Martin Mangino; Ana Bennett; Colin O'Rourke; Toshiro Okamoto; Teresa Diago Uso; John Fung; Kareem Abu-Elmagd; Charles Miller; Cristiano Quintini
Journal:  Liver Transpl       Date:  2014-07-02       Impact factor: 5.799

7.  Sequential cold storage and normothermic perfusion of the ischemic rat liver.

Authors:  H Tolboom; J M Milwid; M L Izamis; K Uygun; F Berthiaume; M L Yarmush
Journal:  Transplant Proc       Date:  2008-06       Impact factor: 1.066

8.  Donation after cardio-circulatory death liver transplantation.

Authors:  Hieu Le Dinh; Arnaud de Roover; Abdour Kaba; Séverine Lauwick; Jean Joris; Jean Delwaide; Pierre Honoré; Michel Meurisse; Olivier Detry
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

9.  Liver transplantation from a non-heart-beating donor after pulmonary failure: report of a case.

Authors:  Walid Faraj; Gabriele Marangoni; Faisal Dar; Deborah Mukherji; Nigel Heaton; Paolo Muiesan
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

10.  Mutations to bid cleavage sites protect hepatocytes from apoptosis after ischemia/reperfusion injury.

Authors:  Erica Riddle-Taylor; Kazuhito Nagasaki; Joseph Lopez; Carlos O Esquivel; Olivia M Martinez; Sheri M Krams
Journal:  Transplantation       Date:  2007-09-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.